Precision for Value

Payers to pharma: Here’s what we’re missing in hep C drugsA Precision for Value survey highlights what can be done in order to encourage payers to ease coverage policies for these drugs in the next wave of HCV treatment.
Five healthcare policies to expect under President TrumpAs Donald Trump was sworn in as the 45th U.S. president, health policy experts share with Managed Healthcare Executive what’s next for healthcare.
Seven ways the blocked Aetna-Humana merger affects the industryThe proposed megamerger has been shot down. Find out what it means for healthcare execs.